Is Divis a MNC company?
Divi’s Laboratories is India’s second most valuable pharmaceutical company by market capitalization….Divi’s Laboratories.
Divi’s Laboratories’ logo | |
---|---|
Formerly | Divi’s Research Centre |
Type | Public |
Traded as | BSE: 532488 NSE: DIVISLAB NSE NIFTY 50 Constituent |
ISIN | INE361B01024 |
What Divis Lab do?
Divi’s Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies.
Is Divis Lab debt free company?
With a near debt-free balance sheet and strong, predictable cash flow, Divis continues to exhibit robust performance aided by its strong business model.
How many branches of Divis Laboratories are there?
The company has four manufacturing facilities and market presence across several countries. The first facility is located at village Lingojigudem in Yadadri Bhuvanagiri District near Hyderabad (Telangana) comprises 11 multipurpose production blocks with finished product areas for APIs.
Who is the founder of Divis Lab?
Murali DiviDivi’s Laboratories / Founder
Murali Divi is the founder of Divi’s Labs, one of the top three manufacturers of active pharmaceutical ingredients (API).
Is Divis Labs a good buy for long term?
Divi’s Laboratories’s Earnings Per Share Are Growing. As a tree reaches steadily for the sky, Divi’s Laboratories’s EPS has grown 24% each year, compound, over three years. The good news is that Divi’s Laboratories is growing revenues, and EBIT margins improved by 2.8 percentage points to 38%, over the last year.
Is TCS debt free?
3] Tata Consultancy Services or TCS: This is another large-cap IT company stock with zero debt and high alpha feature. This company is also a debt-free company that has generated more return than the benchmark index.
Is Divis Labs a good buy?
Divi’s Laboratories’s Earnings Per Share Are Growing. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. The good news is that Divi’s Laboratories is growing revenues, and EBIT margins improved by 2.8 percentage points to 38%, over the last year.
Who is Nilima Motaparti?
Nilima Motaparti is the daughter of Pharma legend Murali Krishna Prasad Divi. Her father is the founder of Divi Laboratories and also the Richest man in Telugu states. Nilima Motaparti administers all aspects of Material Sourcing and Procurement, Corporate Finance and Investor Relations in Divi labs.
Is it good to invest in Divis Lab?
What is the intrinsic value of Divis Lab?
Divis Laboratories
As Of | Intrinsic Value | Market Price |
---|---|---|
31 Dec 2021 | Rs. 1,793.87 | Rs. 4,678.20 |
15 Feb 2022 | —- | Rs. 4,325.80 |
47.90 1.11% |
Is Wipro debt free?
What Is Wipro’s Debt? The image below, which you can click on for greater detail, shows that at September 2021 Wipro had debt of ₹114.2b, up from ₹74.5b in one year. However, it does have ₹316.6b in cash offsetting this, leading to net cash of ₹202.4b.